Preventing Spinal Infection: Ultrasound Triggered Prophylaxis
预防脊柱感染:超声触发预防
基本信息
- 批准号:9898313
- 负责人:
- 金额:$ 52.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAnti-Bacterial AgentsAntibiotic ResistanceAntibiotic TherapyAntibioticsAreaAttenuatedAwarenessBacteriaBiocompatible MaterialsClinicalCombined AntibioticsComplicationEngineeringEnsureEthersEvaluationFree WillGenerationsGoalsGovernmentHistologyHospitalsImmuneImmunohistochemistryImplantIn VitroInfectionInfection preventionKetonesKineticsLaboratoriesLongevityMeasuresMechanicsMinimum Inhibitory Concentration measurementModelingMonitorOperative Surgical ProceduresOryctolagus cuniculusPainPatient DischargePatientsPerioperativePersonsPorosityPostoperative PeriodPredispositionProphylactic treatmentResearchResistanceRetrievalRodRuptureSamplingScientistSiteSpinalSpinal FusionSpine surgerySurfaceSurgeonSurgical Wound InfectionSystemTestingTherapeuticThickTimeTissuesToxic effectTranslatingTraumatic injuryTreatment CostUltrasonographyVancomycinantimicrobialbonecostdesigndisabilitydrug resistant pathogenin vivo Modelinfection rateinnovationinstrumentmortalitypathogenpreventprophylacticpublic health relevancesealspine bone structuresubstantia spongiosa
项目摘要
DESCRIPTION: Despite aggressive peri-operative antibiotic treatments, between 1 in 20 and 1 in 100 patients undergoing spinal surgery develop an infection. For patients with traumatic injury, these rates easily exceed 10%. With > 5 million annual surgeries by 2030 and only partially effective infection treatments, the cost and disability due to infection will continue to
mount. More effective means to prevent infection are therefore a clinical imperative. To be most effective, new treatments must eradicate pathogens before their adherence to the implant surface attenuates antibiotic and immune susceptibility. Aware of this requirement, our laboratories have long focused on new ways to create antibacterial implant systems that prevent bacterial colonization. Our hypothesis is that maintaining supra-therapeutic antibiotic concentrations at the hardware site during the peri-operative period will prevent establishment of infection and lower infection rates. To test this, we propose to develop a simple porous polyether ether ketone (PEEK) sheath that surrounds the spinal rod and releases its contents--mg quantities of a combination of antibiotics--upon application of ultrasound (US); all antibiotics
will be released from sheaths during the peri-operative period to ensure aggressive prophylaxis. Use of antibiotic combinations is expected to minimize antibiotic resistant pathogens and to ensure that all contaminating pathogens are eradicated. There are three specific aims 1: To characterize the stability and release kinetics of an US-activated antimicrobial release system. 2: To test the ability of the sheaths to prevent bacterial colonization of adjacent hardware in vitro. 3: To determine the utility of the sheath in eradicating infection in an in vivo model of infection. The approach detailed in this application ensures eradication of pathogens in the immediate post-operative period. The concept and impetus has arisen through the efforts of a spinal surgeon, US physicist, basic scientist (implant infections), and biomaterials engineer (PEEK and implant retrieval and analysis). It directly addresses the problem of spinal implant infections using innovative applications of proven materials that upon completion of this project can quickly and effectively be translated to the clinical arena. We anticipate that this therapy wil further lower infection rates and ameliorate the pain, suffering, disability, and mortality associated with infections that occur after spinal surgery.
描述:尽管在围手术期进行了积极的抗生素治疗,但对于遭受创伤的患者,仍有二十分之一至一百人中出现感染,到 2030 年,每年进行的手术数量将超过 500 万例,而这一比例很容易超过 10%。有效的感染治疗,感染造成的费用和残疾将继续
因此,为了最有效地预防感染,新的治疗方法必须在病原体附着在种植体表面削弱抗生素和免疫敏感性之前将其消灭,我们的实验室长期以来一直致力于寻找新的方法。创建防止细菌定植的抗菌植入系统。我们的假设是,在围手术期在硬件部位维持超治疗抗生素浓度将防止感染并降低感染率。建议开发一种简单的多孔聚醚醚酮 (PEEK) 护套,该护套在应用所有抗生素后包围脊柱杆及其内容物(毫克量的抗生素组合);
将在围手术期从鞘中释放,以确保使用抗生素组合可最大程度地减少抗生素耐药性病原体,并确保根除所有污染病原体。有三个具体目标 1:表征稳定性和释放。美国激活的抗菌释放系统的动力学 2:测试护套在体外防止邻近硬件细菌定植的能力。在感染的体内模型中根除感染的方法确保在术后立即根除病原体这一概念和推动力是通过脊柱外科医生、美国物理学家、基础科学家(植入物感染)的努力而提出的。 )和生物材料工程师(PEEK 和植入物检索和分析),它使用经过验证的材料的创新应用直接解决脊柱植入物感染的问题,我们预计这些材料在完成该项目后可以快速有效地转化为临床领域。这种疗法将进一步降低感染率,并改善与脊柱手术后发生的感染相关的疼痛、痛苦、残疾和死亡率。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Staphylococcus aureus Floating Biofilm Formation and Phenotype in Synovial Fluid Depends on Albumin, Fibrinogen, and Hyaluronic Acid.
- DOI:10.3389/fmicb.2021.655873
- 发表时间:2021
- 期刊:
- 影响因子:5.2
- 作者:Knott S;Curry D;Zhao N;Metgud P;Dastgheyb SS;Purtill C;Harwood M;Chen AF;Schaer TP;Otto M;Hickok NJ
- 通讯作者:Hickok NJ
Does annealing improve the interlayer adhesion and structural integrity of FFF 3D printed PEEK lumbar spinal cages?
- DOI:10.1016/j.jmbbm.2019.103455
- 发表时间:2020-02-01
- 期刊:
- 影响因子:3.9
- 作者:Basgul, Cemile;Yu, Tony;Kurtz, Steven M.
- 通讯作者:Kurtz, Steven M.
3D printed porous PEEK created via fused filament fabrication for osteoconductive orthopaedic surfaces.
- DOI:10.1016/j.jmbbm.2020.103850
- 发表时间:2020-05
- 期刊:
- 影响因子:3.9
- 作者:H. Spece;T. Yu;Anthony Law;M. Marcolongo;Steven M. Kurtz
- 通讯作者:H. Spece;T. Yu;Anthony Law;M. Marcolongo;Steven M. Kurtz
Bacterial toxins in musculoskeletal infections.
- DOI:10.1002/jor.24683
- 发表时间:2021-03
- 期刊:
- 影响因子:0
- 作者:Saeed K;Sendi P;Arnold WV;Bauer TW;Coraça-Huber DC;Chen AF;Choe H;Daiss JL;Ghert M;Hickok NJ;Nishitani K;Springer BD;Stoodley P;Sculco TP;Brause BD;Parvizi J;McLaren AC;Schwarz EM
- 通讯作者:Schwarz EM
Are Medical Grade Bioabsorbable Polymers a Viable Material for Fused Filament Fabrication?
- DOI:10.1115/1.4043841
- 发表时间:2019-07
- 期刊:
- 影响因子:0
- 作者:J. Schachtner;M. Frohbergh;N. Hickok;S. Kurtz
- 通讯作者:J. Schachtner;M. Frohbergh;N. Hickok;S. Kurtz
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Flemming Forsberg其他文献
Flemming Forsberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Flemming Forsberg', 18)}}的其他基金
Vevo 3100 ultrasound scanner and PV loop system
Vevo 3100 超声波扫描仪和 PV 环路系统
- 批准号:
10177118 - 财政年份:2021
- 资助金额:
$ 52.09万 - 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
- 批准号:
10472567 - 财政年份:2020
- 资助金额:
$ 52.09万 - 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
- 批准号:
10199974 - 财政年份:2020
- 资助金额:
$ 52.09万 - 项目类别:
Prostate Cancer Diagnosis by Multiparametric Ultrasound
多参数超声诊断前列腺癌
- 批准号:
10032625 - 财政年份:2020
- 资助金额:
$ 52.09万 - 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
- 批准号:
10217039 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
- 批准号:
9337418 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
- 批准号:
9185490 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis
预防脊柱感染:超声触发预防
- 批准号:
9233017 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
Detection of High Grade Prostate Cancer with Subharmonic Ultrasound Imaging
用次谐波超声成像检测高级别前列腺癌
- 批准号:
9024279 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
Optimizing Ultrasound Enhanced Delivery of Therapeutics
优化超声增强治疗的输送
- 批准号:
10612329 - 财政年份:2016
- 资助金额:
$ 52.09万 - 项目类别:
相似国自然基金
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs
追求一站式服务:针对注射吸毒者的全面减少远程伤害的混合 1 型有效性实施试验
- 批准号:
10680988 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别:
2023 Microbial Adhesion and Signal Transduction Gordon Research Conferences and Seminar
2023年微生物粘附和信号转导戈登研究会议和研讨会
- 批准号:
10666171 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别:
A Bio-controlled, Microbiota-Sparing, Live Biotherapeutic Anti-Infective for Clostridioides difficile
一种针对艰难梭菌的生物控制、保留微生物群的活生物治疗抗感染药物
- 批准号:
10586070 - 财政年份:2022
- 资助金额:
$ 52.09万 - 项目类别:
Formulation development and testing of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections
用于预防怀孕和性传播感染的新型非激素阴道环的配方开发和测试
- 批准号:
10493312 - 财政年份:2021
- 资助金额:
$ 52.09万 - 项目类别:
Silver Carboxylate-Eluting Titanium Dioxide/Polydimethyl Siloxane Antibiotic-Independent Antimicrobial Coating as a Safe and Efficacious Alternative for Antibiotic Resistance
羧酸银洗脱二氧化钛/聚二甲基硅氧烷不依赖抗生素的抗菌涂层作为抗生素耐药性的安全有效替代品
- 批准号:
10374141 - 财政年份:2021
- 资助金额:
$ 52.09万 - 项目类别: